<DOC>
	<DOC>NCT00971269</DOC>
	<brief_summary>The study is an open, prospective, single-site study where 16 patients suffering from fecal incontinence will be included. Change in fecal incontinence episodes after intersphincteric injection of NASHA/Dx gel 4x2 ml and retreatment 4x2 ml after 4 weeks will be measured.</brief_summary>
	<brief_title>Pilot Study of NASHA/Dx Gel for Fecal Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Fecal Incontinence</mesh_term>
	<criteria>1. Fecal incontinence with at least 2 episodes/week 2. Symptom duration at least one year 3. Failed attempt of conservative therapy 4. Age 1880 5. Written informed consent 6. Available for followup 7. Fully compliant with protocol 1. Active inflammatory bowel disease 2. Total external sphincter defect at ultrasound and clinical examination 3. Bleeding diathesis or anticoagulant therapy 4. Rectal prolapse or intussusceptions 5. Present anal sepsis 6. Anorectal implants 7. Recent anorectal surgery (within 6 months) 8. Rectal anastomosis 9. Pregnancy, postpartum (one year) or breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>